Title:
DUAL ANTAGONIST FOR ADENOSINE A2A RECEPTOR AND ADENOSINE A2B RECEPTOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/203267
Kind Code:
A1
Abstract:
Provided are a dual antagonist for adenosine A2A receptor and adenosine A2B receptor, a pharmaceutical composition containing same for prevention or treatment of diseases (e.g., cancer) related to adenosine A2A receptor and adenosine A2B receptor, and a method for treatment and prevention of diseases by using same. According to the present invention, adenosine-related diseases, for example, cancers, can be effectively prevented or treated.
Inventors:
LEE HYO SEON (KR)
KIM SIU (KR)
KIM SIU (KR)
Application Number:
PCT/KR2022/003617
Publication Date:
September 29, 2022
Filing Date:
March 15, 2022
Export Citation:
Assignee:
STANDIGM INC (KR)
International Classes:
C07D405/14; A61K31/506; A61K45/06; A61P35/00
Domestic Patent References:
| WO2020053263A1 | 2020-03-19 |
Foreign References:
| KR20190104610A | 2019-09-10 | |||
| KR20070020397A | 2007-02-21 | |||
| KR20200121337A | 2020-10-23 | |||
| KR20200041315A | 2020-04-21 |
Attorney, Agent or Firm:
RYU, Jong Woo et al. (KR)
Download PDF:
Previous Patent: REFRIGERATOR
Next Patent: DEVICE FOR CORRECTING PROCESSING ERROR OF MACHINE TOOL AND METHOD THEREOF
Next Patent: DEVICE FOR CORRECTING PROCESSING ERROR OF MACHINE TOOL AND METHOD THEREOF